ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
AC062017.1 | Uncharacterized protein | | | | | | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | | | | | Group enriched |
ADGB | Androglobin | Enzymes
| | | | | Group enriched |
AKAP14 | A kinase (PRKA) anchor protein 14 | | | | | | Group enriched |
AMH | Anti-Mullerian hormone | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
ANKRD61 | Ankyrin repeat domain 61 | | | | | | Group enriched |
AOC2 | Amine oxidase, copper containing 2 (retina-specific) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
APOBEC4 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative) | | | | | | Group enriched |
ARMC3 | Armadillo repeat containing 3 | | | | | | Group enriched |
ARMC4 | Armadillo repeat containing 4 | Disease related genes
| | | | | Group enriched |
ARMS2 | Age-related maculopathy susceptibility 2 | Disease related genes Mitochondrial proteins
| | | | | Group enriched |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BNC1 | Basonuclin 1 | Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
BSN | Bassoon presynaptic cytomatrix protein | Plasma proteins
| | | | | Group enriched |
C10orf67 | Chromosome 10 open reading frame 67 | | | | | | Group enriched |
C10orf90 | Chromosome 10 open reading frame 90 | | | | | | Group enriched |
C11orf70 | Chromosome 11 open reading frame 70 | | | | | | Group enriched |
C14orf164 | Chromosome 14 open reading frame 164 | | | | | | Group enriched |
C14orf23 | Chromosome 14 open reading frame 23 | | | | | | Group enriched |
C16orf71 | Chromosome 16 open reading frame 71 | | | | | | Group enriched |
C1orf111 | Chromosome 1 open reading frame 111 | | | | | | Group enriched |
C1orf141 | Chromosome 1 open reading frame 141 | | | | | | Group enriched |
C1orf158 | Chromosome 1 open reading frame 158 | | | | | | Group enriched |
C1orf167 | Chromosome 1 open reading frame 167 | | | | | | Group enriched |
C1orf173 | Chromosome 1 open reading frame 173 | | | | | | Group enriched |
C1orf177 | Chromosome 1 open reading frame 177 | | | | | | Group enriched |
C1orf189 | Chromosome 1 open reading frame 189 | | | | | | Group enriched |
C1orf194 | Chromosome 1 open reading frame 194 | | | | | | Group enriched |
C1orf87 | Chromosome 1 open reading frame 87 | | | | | | Group enriched |
C20orf26 | Chromosome 20 open reading frame 26 | Predicted membrane proteins
| | | | | Group enriched |
C2orf70 | Chromosome 2 open reading frame 70 | | | | | | Group enriched |
C2orf73 | Chromosome 2 open reading frame 73 | | | | | | Group enriched |
C2orf81 | Chromosome 2 open reading frame 81 | | | | | | Group enriched |
C4orf22 | Chromosome 4 open reading frame 22 | | | | | | Group enriched |
C5orf49 | Chromosome 5 open reading frame 49 | | | | | | Group enriched |
C6ORF165 | UPF0704 protein C6orf165 | | | | | | Group enriched |
C9orf116 | Chromosome 9 open reading frame 116 | | | | | | Group enriched |
C9orf135 | Chromosome 9 open reading frame 135 | | | | | | Group enriched |
C9orf171 | Chromosome 9 open reading frame 171 | | | | | | Group enriched |
C9orf24 | Chromosome 9 open reading frame 24 | | | | | | Group enriched |
C9orf9 | Chromosome 9 open reading frame 9 | | | | | | Group enriched |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CAND2 | Cullin-associated and neddylation-dissociated 2 (putative) | | | | | | Group enriched |
CASC1 | Cancer susceptibility candidate 1 | | | | | | Group enriched |
CATSPERD | Catsper channel auxiliary subunit delta | Predicted membrane proteins Transporters
| | | | | Group enriched |
CCDC103 | Coiled-coil domain containing 103 | Disease related genes
| | | | | Group enriched |